by Dr Rath MD
http://www4.dr-rath-foundation.org/PHARMACEUTICAL_BUSINESS/laws_of_the_pharmaceutical_industry.htmThe main principles governing the pharmaceutical "business with
disease." It is not in the financial interests of the pharmaceutical
industry to prevent common diseases – the maintenance and expansion of
diseases is a precondition for the financial growth of this industry.
1
The pharmaceutical industry is an investment industry driven by the
profits of its shareholders. Improving human health is not the driving
force of this industry.

2
The pharmaceutical investment industry was artificially created and
strategically developed over an entire century by the same investment
groups that control the global petrochemical and chemical industries.

3
The huge profits of the pharmaceutical industry are based on the
patenting of new drugs. These patents essentially allow drug
manufacturers to arbitrarily define the profits for their products.

4
The marketplace for the pharmaceutical industry is the human body –
but only for as long as the body hosts diseases. Thus, maintaining and
expanding diseases is a precondition for the growth of the
pharmaceutical industry.

5
A key strategy to accomplish this goal is the development of drugs
that merely mask symptoms while avoiding the curing or elimination of
diseases. This explains why most prescription drugs marketed today
have no proven efficacy and merely target symptoms.

6
To further expand their pharmaceutical market, the drug companies are
continuously looking for new applications (indications) for the use of
drugs they already market. For example, Bayer's pain pill Aspirin is
now taken by 50 million healthy US citizens under the illusion it will
prevent heart attacks.

7
Another key strategy to expand pharmaceutical markets is to cause new
diseases with drugs. While merely masking symptoms short term, most of
the prescription drugs taken by millions of patients today cause a
multitude of new diseases as a result of their known long-term side
effects. For example, all cholesterol-lowering drugs currently on the
market are known to increase the risk of developing cancer – but only
after the patient has been taking the drug for several years.

8
The known deadly side effects of prescription drugs are the fourth
leading cause of death in the industrialized world, surpassed only by
the number of deaths from heart attacks, cancer and strokes (Journal
of the American Medical Association, April 15, 1998). This fact is no
surprise either, because drug patents are primarily issued for new
synthetic molecules. All synthetic molecules need to be detoxified and
eliminated from the body, a system that frequently fails and results
in an epidemic of severe and deadly side effects.

9
While the promotion and expansion of diseases increase the market of
the pharmaceutical investment industry - prevention and root cause
treatment of diseases decrease long-term profitability; therefore,
they are avoided or even obstructed by this industry.

10
Worst of all, the eradication of diseases is by its very nature
incompatible with and diametrically opposed to the interests of the
pharmaceutical investment industry. The eradication of diseases now
considered as potential drug markets will destroy billions of
investment dollars and eventually will eliminate this entire industry.

11
Vitamins and other effective natural health therapies that optimize
cellular metabolism threaten the pharmaceutical "business with
disease" because they target the cellular cause of today's most common
diseases - and these natural substances cannot be patented.

12
Throughout the more than one hundred year existence of the
pharmaceutical industry, vitamins and other essential nutrients, with
defined functions as cofactors in cellular metabolism, have been the
fiercest competition and the greatest threat to the long-term success
of the pharmaceutical investment business.

13
Vitamins and other effective natural health therapies that effectively
prevent diseases are incompatible with the very nature of the
pharmaceutical "business with disease."

14
To protect the strategic development of its investment business
against the threat from effective, natural and non-patentable
therapies, the pharmaceutical industry has – over an entire century -
used the most unscrupulous methods, such as:

(1) Withholding life-saving health information from millions of
people. It is simply unacceptable that today so few know that the
human body cannot produce vitamin C and lysine, two key molecules for
connective tissue stability and disease prevention.

(2) Discrediting natural health therapies. The most common way is
through global PR campaigns organized by the Pharma-Cartel that spread
lies about the alleged side effects of natural substances – molecules
that have been used by Nature for millennia.

(3) Banning by law the dissemination of information about natural
health therapies. To that end, the pharmaceutical industry has placed
its lobbyists in key political positions in key markets and leading
drug export nations.

15
The pharmaceutical "business with disease" is the largest deception
and fraud business in human history. The product "health" promised by
drug companies is not delivered to millions of patients. Instead, the
"products" most often delivered are the opposite: new diseases and
frequently, death.

16
The survival of the pharmaceutical industry is dependent on the
elimination by any means of effective natural health therapies. These
natural and non-patentable therapies have become the treatment of
choice for millions of people despite the combined economic, political
and media opposition of the world's largest investment industry.